The US Has 3 Covid Vaccines—Testing New Ones Is Complicated

Now that authorized versions are available, it’s tough to recruit volunteers for trials that might give them a placebo. But there are other options.

Akanksha Schwarz doesn’t know which shot she got. She’s part of a clinical trial testing Novavax’s experimental Covid-19 vaccine, a blinded study that injected participants with either the real thing or a placebo. But recently, Schwarz became eligible for one of the three vaccines already cleared by the Food and Drug Administration for public use in the US. Now, she’s got a tough call to make.

Schwarz could stay in the study to help Novavax’s candidate cross the testing finish line. As an

→ Continue reading at Wired - Science

More from author

Related posts


Latest posts

Deliveroo could leave Spanish market ahead of on-demand labor reclassification

Deliveroo announced today that it is considering leaving the Spanish market, citing limited market share and a long road of investment with “highly uncertain...

For tech firms, the risk of not preparing for leadership changes is huge

Jason Dressel Contributor Jason Dressel is president of History Factory, which helps companies use their history and...

5 Reasons Why Employees Prefer Self-Employment, and Why You Should Use This to Your Advantage

Find employees that care about your business as if it was their own. Free Book Preview: Unstoppable Get a glimpse...